Ionis Pharma

@ionispharma

Delivering innovative medicines to patients where no others have proven effective or existed. See our community guidelines:

Vrijeme pridruživanja: prosinac 2015.

Tweetovi

Blokirali ste korisnika/cu @ionispharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ionispharma

  1. Prikvačeni tweet
    7. svi 2019.
    Poništi
  2. 31. sij

    Only 2 weeks left to apply for an intership at Ionis! Take a look at our job board for all open summer intern positions here:

    Poništi
  3. 31. sij

    Ion Michael McCaleb, VP of Clinical Development, sums up what saying is all about at Ionis.

    Poništi
  4. 29. sij

    Here's what Ion Frank Rigo, VP of Functional Genomics, had to say about turning yes into in 2020? Are you saying ?

    Poništi
  5. 28. sij

    Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx. Read more:

    Poništi
  6. 28. sij
    Poništi
  7. 28. sij

    We're cracking the code on neurodegenerative diseases! discussed our validated platform, expanding pipeline, and continued technology advancements during his presentation. Watch the here:

    Poništi
  8. 27. sij

    See how Ion Fiona An, Executive Director of Clinical Development, plans to make yes happen this year!

    Poništi
  9. 24. sij

    Our leadership position in RNA-targeted therapeutics continues to grow as our technology advances. Learn more in the of 's presentation:

    Poništi
  10. 24. sij

    New Year. New opportunities to say Yes, to patients, to science, to innovation. We asked our employees (Ions) what they're hoping to say yes to in 2020. Here's Ion Punit Seth, VP of Medicinal Chemistry.

    Poništi
  11. 23. sij

    Interested in a career in biotech? Check out our summer internships in science, research and development, corporate communications, business operations and more! We’ll be accepting applications until Feb. 14. Apply now!

    Poništi
  12. 22. sij

    Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx

    Poništi
  13. 21. sij

    Couldn’t make it to ? Check out our REPLAY of CEO ’s presentation from the conference.

    Poništi
  14. 15. sij

    Don't forget! Watch CEO 's presentation live from the J.P. Morgan 38th Annual Healthcare Conference today at 7:30 AM PST. Join here:

    Poništi
  15. 10. sij

    Our latest clinical trial site for TTR has launched. Visit to learn about our study for transthyretin mediated amyloid cardiomyopathy (ATTR CM) patients.

    Poništi
  16. 9. sij

    Please join us in welcoming our new Chief Corporate Development and Commercial Officer Onaiza Cadoret-Manier! Read more:

    Poništi
  17. 9. sij

    Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer

    Poništi
  18. 8. sij

    At Ionis, patients are the reason we come to work every day. We are honored to join our colleagues around the world in reinforcing our commitment to improving the lives of the sick people who depend on us. Read more:

    Poništi
  19. 7. sij

    Our franchise closed 2019 with a bang! With pipeline advances, prolific scientific publication & prestigious award recognition, we’ve solidified our position as a leading neuro program. Read more:

    Poništi
  20. 7. sij

    Ionis’ neurological franchise marks year of achievement

    Poništi
  21. 6. sij

    Please join us for a live presentation and webcast featuring our new CEO Brett Monia, Ph.D. at next week’s J.P. Morgan 38th Annual Healthcare Conference.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·